FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
A heart PET scan is a noninvasive imaging test that uses a small amount of radiation. It helps doctors understand how the heart functions and whether it is healthy. Cardiac or heart PET scans create ...
Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...
(Barcelona, Spain, Wednesday 8 September 2025) The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual ...
PET scans can detect amyloid plaques and tau tangles in the brain, which are often early signs of Alzheimer’s disease. But they’re not enough on their own to make a diagnosis. Alzheimer’s disease is ...
Paweł Moskal from Jagiellonian University talks to Tami Freeman about positronium imaging with the unique J-PET scanner and his team’s work in applying quantum entanglement to diagnostics First ...
PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...
Gozellix, a PSMA-PET imaging agent, is FDA-approved for detecting prostate cancer metastasis and recurrence, enhancing access to advanced imaging. The approval is supported by data from the PSMA-PreRP ...
What Is a PSMA PET Scan? A PSMA PET scan, or prostate-specific membrane antigen positron emission tomography scan, is a recently developed imaging test used for people with prostate cancer. It looks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results